Symbiox Investment & Trading Co Ltd (539278) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Symbiox Investment & Trading Co Ltd ₹2.02, price ₹1.52, upside +32.9%, quality 74 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Symbiox Investment & Trading Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹0.7500 – ₹15.57 · fair‑value band ₹1.51 – ₹2.56 · the ₹1.52 price screens below the ₹2.02 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Symbiox Investment & Trading Co in your weekly email
Every Wednesday you see whether Symbiox Investment & Trading Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Symbiox Investment & Trading Co Ltd trades in sarees in India. It offers sarees with embroidery work of stones, beads, etc., including plain, designer, cotton, and silk sarees. The company is also involved in financing activities. Symbiox Investment & Trading Co Ltd was incorporated in 1979 and is based in Kolkata, India.
Stock analysis
Symbiox Investment & Trading Co Ltd (539278) currently trades at ₹1.52, while our model-based Fair Value estimate is ₹2.02, implying the stock looks roughly 24.7% undervalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ₹12.65 per share, and 14 of the 20 models we run sit above the ₹1.52 price.
Bear case: the Earnings-Based group reads lowest at ₹0.7500, and 6 of the 20 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹1.51 (bear) to ₹2.56 (bull), the price of ₹1.52 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Consumer Cyclical sector.
Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Symbiox Investment & Trading Co Ltd reported revenue of ₹16.0M in FY2026 versus ₹10.5M in FY2022, a compound +11.1%/yr. Reported net income was ₹1.5M in FY2026, compounding +2.3%/yr from FY2022.
Key figures
Market cap ₹47.6M (≈ $494K) · P/E ratio 124.2 · P/S ratio 11.8 · EPS (TTM) ₹0.0066 · Net margin 9.5% · Return on assets (EBIT) 0.0% · Free cash flow ₹27.3M · Net debt ₹2.5M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 58% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −19% fair-value upside, at 33%, 539278 screens cheaper than that median.
Fair Value models
Bear ₹1.51Fair Value ₹2.02Bull ₹2.56
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.0034 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+17.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+17.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.17.0% vs 3.1%, picking up
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−44% → 13%
Compare Symbiox Investment & Trading Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 332 stocks
Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside+32.9% · Above median
Profitability
Return on assets0.0% · Below median
Net margin (TTM)9.5% · Top 25%
Operating margin (TTM)0.0% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Valuation Multiplesvs Textile Manufacturing median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Symbiox Investment & Trading Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/539278
Frequently asked questions
Is Symbiox Investment & Trading Co Ltd (539278) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹2.02 versus a price of ₹1.52, about +33% upside (undervalued).
What is the fair value of 539278?
Our model-based fair value for Symbiox Investment & Trading Co Ltd is ₹2.02 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹1.52.
What is the quality score of 539278?
Symbiox Investment & Trading Co Ltd has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Symbiox Investment & Trading Co Ltd (539278)?
Our model-based price target is the fair value of ₹2.02 (as of Sep 27, 2026) from 20 valuation models. Cautious scenario ₹1.51, optimistic scenario ₹2.56. It is a calculation from audited fundamentals, not an analyst target.
What is the Symbiox Investment & Trading Co Ltd stock forecast for 2026?
Our models put fair value at ₹2.02, about +33% upside versus a price of ₹1.52 (undervalued). Cautious scenario ₹1.51, optimistic scenario ₹2.56. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Symbiox Investment & Trading Co Ltd (539278)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Symbiox Investment & Trading Co Ltd it is ₹2.02 per share (as of Sep 27, 2026), against a price of ₹1.52. It is the blended result of 20 valuation models (cash flow, earnings, asset, dividend).
Is Symbiox Investment & Trading Co Ltd stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 539278 trades below its calculated fair value: price ₹1.52, fair value ₹2.02, a gap of about +33% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 539278?
No. The price is what the market pays today (₹1.52); the fair value is what the company's own numbers justify (₹2.02). For Symbiox Investment & Trading Co Ltd the two are ₹0.5000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Symbiox Investment & Trading Co Ltd worth?
The market values Symbiox Investment & Trading Co Ltd at about ₹47.6M (market capitalisation, as of Sep 27, 2026). Per share that is ₹1.52; our models calculate a fair value of ₹2.02 per share.
What do the bullish and bearish scenarios say about 539278?
Our models span a range for Symbiox Investment & Trading Co Ltd: cautious scenario ₹1.51, base ₹2.02, optimistic ₹2.56 per share (as of Sep 27, 2026, price ₹1.52). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 539278?
Symbiox Investment & Trading Co Ltd trades at a price-to-earnings ratio of 124.2 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹2.02 is built from several models across several years.
How far is 539278 from its 52-week high?
Symbiox Investment & Trading Co Ltd trades at ₹1.52, about 58% below its 52-week high of ₹3.59 and 4% above the low of ₹1.46 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹2.02 is for.
Which stocks are comparable to Symbiox Investment & Trading Co Ltd?
From the same area (Consumer Cyclical) we also value Tongkun Group, Shenzhou International Group, Inner Mongolia ERDOS Resources Co, K.P.R. Mill Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Symbiox Investment & Trading Co Ltd stock attractive at the current price?
The data as of Sep 27, 2026: price ₹1.52, calculated fair value ₹2.02 (+33%), Quality Score 74/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 539278 calculated?
We run Symbiox Investment & Trading Co Ltd through 20 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹2.02, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Symbiox Investment & Trading Co Ltd currently trades 25 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Symbiox Investment & Trading Co Ltd (539278)?
The closing price on Oct 1, 2026 was ₹1.52. Our model-based fair value is ₹2.02, about +33% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Symbiox Investment & Trading Co Ltd right now?
The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Symbiox Investment & Trading Co Ltd
How large is the market capitalisation of Symbiox Investment & Trading Co Ltd (539278)?
The market capitalisation of Symbiox Investment & Trading Co Ltd is ₹47.6M (≈ $494K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Symbiox Investment & Trading Co Ltd (539278)?
The price-to-sales ratio of Symbiox Investment & Trading Co Ltd is 11.8 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Symbiox Investment & Trading Co Ltd (539278)?
Earnings per share at Symbiox Investment & Trading Co Ltd are ₹0.0066 (price ÷ EPS = P/E 124.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Symbiox Investment & Trading Co Ltd (539278)?
The net margin of Symbiox Investment & Trading Co Ltd is 9.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Symbiox Investment & Trading Co Ltd (539278)?
On an EBIT basis the return on assets of Symbiox Investment & Trading Co Ltd is 0.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Symbiox Investment & Trading Co Ltd (539278) generate?
The free cash flow of Symbiox Investment & Trading Co Ltd is ₹27.3M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Symbiox Investment & Trading Co Ltd (539278) carry?
The net debt of Symbiox Investment & Trading Co Ltd is ₹2.5M (fiscal year 2020, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Symbiox Investment & Trading Co Ltd in the live analysis
One click puts Symbiox Investment & Trading Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
